TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Kilitch Drugs (India) Limited ( (IN:KILITCH) ) has issued an update.
Kilitch Drugs (India) Limited has announced its 33rd Annual General Meeting (AGM) scheduled for September 26, 2025, to be conducted via video conferencing. The AGM will address ordinary business such as the adoption of financial statements and the reappointment of directors, including Mr. Bhavin Mehta and Mr. Mukund Mehta, the latter as Managing Director for another five years. This meeting is significant for stakeholders as it involves key decisions on leadership and financial strategies that could impact the company’s future operations and market positioning.
More about Kilitch Drugs (India) Limited
Kilitch Drugs (India) Limited operates in the pharmaceutical industry, focusing on the production and distribution of drugs and related healthcare products. The company is based in Mumbai, India, and is known for its contributions to the pharmaceutical sector, often referred to as the ‘Pharmacy of the World.’
Average Trading Volume: 2,427
Technical Sentiment Signal: Hold
Current Market Cap: 5.91B INR
For detailed information about KILITCH stock, go to TipRanks’ Stock Analysis page.